IndraLab

Statements


USP20 ubiquitinates RIPK1. 2 / 2
| 1 1

reach
"USP20 reduces atherogenic signaling in smooth muscle cells by deubiquitinating RIPK1 (receptor interacting serine/threonine kinase 1) in response to TNF (tumor necrosis factor) and IL1B (interleukin 1 beta) stimulation [51]."

sparser
"Antagonizing USP20 activity in SMCs by low-level overexpression of DN-USP20 augmented TNF-induced RIPK1 ubiquitination ( xref )."